Similarly, alteration of NOTCH2 splicing (skipping of exons 12 or 17 and 18) observed in AML CD34+ cells, but not in normal control cells seems to alter its function, at least in terms of stimulation of HES1 and HEY1 transcription [98]. This evidence concerns the gene CD34 and acute myeloid leukemia.